Potential adverse interaction between aspirin and lisinopril in hypertensive rats

Human and Experimental Toxicology

Volumn 22, Issue 3, 2003, Pages 143-147

  Dubey, Kiran ^a   Balani, D K ^b   Pillai, K K ^a  

^a HAMDARD UNIVERSITY   (India)

^b CCS HARYANA AGRICULTURAL UNIVERSITY   (India)

Author keywords

ACE inhibitors; Aspirin; Drug interactions

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOCORTICOID; LISINOPRIL; METHYLPREDNISOLONE ACETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DOSE RESPONSE; HEART MUSCLE NECROSIS; HISTOPATHOLOGY; HYPERTENSION; HYPOTENSION; KIDNEY INJURY; KIDNEY PARENCHYMA; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SURVIVAL; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ASPIRIN; BLOOD PRESSURE; BODY WEIGHT; DRUG ANTAGONISM; HEMODYNAMIC PROCESSES; HYPERTENSION; KIDNEY; LISINOPRIL; MALE; MYOCARDIUM; PLATELET AGGREGATION INHIBITORS; RATS; RATS, WISTAR; SURVIVAL RATE;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0242500980     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327103ht331oa     Document Type: Article

References (25)

1. Second International Study of Infarct Survival (ISIS-2) Collaborative group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; ii: 349-60.
2. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - I: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81-106.
3. Cohn JN, Johnson G, Ziesche S et al. A comparison of enalapril with hydralazine, isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325: 303-10.
4. Kober L, Torp-Pedersen C, Carlsen JE et al. A clinical trial of the angiotension-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995; 333: 1670-76.
5. Nguyen KN, Aursnes I, Kjekshus J. Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Co-operative New Scandinavian Enalapril Survival Study II (CONSENSUS II). Am J Cardiol 1997; 79: 115-19.
6. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821-28.
7. Al-Khadra AS, Salem DN, Rand WM, Udelson JE, Smith JJ, Konstam MA. Antiplatelet agents and survival: a cohort analysis from the studies of left ventricular dysfunction (SOLVD) trial. J Am Coll Cardiol 1998; 31: 419-25.
8. Leor J, Reicher-Reiss H, Goldbourt U, Boyko V, Gottlieb S, Battler A at al. Aspirin and mortality in patients treated with angiotensin converting enzyme inhibitors. A cohort study of 11,575 patients with coronary artery disease. J Am Coll Cardiol 1999; 33: 1920-25.
9. Latini R, Tognoni G, Maggioni AP et al. Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin. Systematic overview of individual data from 96,712 randomized patients. J Am Coll Cardiol 2000; 35: 1801-807.
10. Fourth International study of Infarct Survival (ISIS-4) Collaborative Group. ISIS 4: a randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669-85.
11. Ribeiro AB, Franco RJS, Kohlman O Jr, Marson O, Ramos OL. Etiopathogenesis of excess methylprednisolone arterial hypertension in the rat. Clin Exp Hypertens 1981; 3: 1219-37.
12. Elijovich F, Krakoff LR. Effect of converting enzyme inhibition on glucocorticoid hypertension in the rat. Am J Physiol 1980; 238: H844-48.
13. Teerlink JR, Massie BM. The interaction of ACE inhibitors and aspirin in heart failure: torn between two lovers. Am Heart J 1999; 138: 193-97.
14. Hall D. The aspirin-angiotensin converting enzyme inhibitor trade off: to halve and halve not. J Am Coll Cardiol 2000; 35: 1808-12.
15. Nawarskas JJ, Spinler SA. Update on the interaction between aspirin and angiotensin converting enzyme inhibitors. Pharmacotherapy 2000; 20: 698-710.
16. Song KH, Fedyk R, Hoover R. Interaction of ACE inhibitors and aspirin in patients with congestive heart failure. Ann Pharmacother 1999; 33: 375-77.
17. Nawarskas JJ, Spinler SA. Does aspirin interfere with the therapeutic efficacy of angiotensin converting enzyme inhibitors in hypertension or congestive heart failure? Pharmacotherapy 1998; 18: 1041-52.
18. Guazzi MD, Campodonico J, Celeste F, Guazzi M, Santambrogio G, Rossi M et al. Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin counteraction. Clin Pharmacol Ther 1998; 63: 79-86.
19. Nagamatsu Y, Tsujioka Y, Hashimoto M, Giddings JC, Yamamoto J. The differential effects of aspirin on platelets, leucocytes and vascular endothelium in an in vivo model of thrombus formation. Clin Lab Haematol 1999; 21: 33-40.
20. Shimazawa M, Takiguchi Y, Umemura K, Kondo K, Nakashima M. Antithrombotic effects in a rat model of aspirin-insensitive arterial thrombosis of desethyl KBT-3022, the main active metabolite of a new anti-platelet agent, KBT-3022. Eur J Pharmacol 1997; 328: 183-89.
21. Herbert JM, Bernat A, Samama M, Maffrand JP. The antiaggregating and antithrombotic activity of Ticlopidine is potentiated by aspirin in the rat. Thromb Heamost 1996; 76: 94-98.
22. Kalkman EAJ, Suylen RJV, Dijk JPMV, Saxena PR, Schoemaker RG. Chronic aspirin treatment affects collagen deposition in non-infarcted myocardium during remodeling after coronary artery ligation in the rat. J Mol Cell Cardiol 1995; 27: 2483-94.
23. Aspirin Myocardial Infarction Study Research Group. A randomized controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 1980; 243: 661-68.
24. Klimt C, Knatterud GL, Stamler J, Meier P. Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin. J Am Coll Cardiol 1986; 7: 251-69.
25. Durak I, Karaavvaz M, Cimen MYB, Avci A, Cimen OB, Buvukkocak et al. Aspirin impairs antioxidant system and causes peroxidation in human erythrocytes and guinea pig myocardial tissue. Human Exp Toxicol 2001; 20: 34-37.